Strategic treatment interruptions during imatinib treatment of chronic myelogenous leukemia

DOI10.1007/S11538-010-9553-0zbMath1215.92035OpenAlexW2099840192WikidataQ30984215 ScholiaQ30984215MaRDI QIDQ545621

Dana Paquin, Doron Levy, Peter P. Lee, Peter S. Kim

Publication date: 22 June 2011

Published in: Bulletin of Mathematical Biology (Search for Journal in Brave)

Full work available at URL: http://europepmc.org/articles/pmc3862185

Mathematics Subject Classification ID

Probabilistic models, generic numerical methods in probability and statistics (65C20) Dynamical systems in biology (37N25) Medical applications (general) (92C50)

Related Items (9)

Stability and controllability issues in mathematical modeling of the intensive treatment of leukemia ⋮ A mathematical model with time-varying delays in the combined treatment of chronic myeloid leukemia ⋮ To cure or not to cure: consequences of immunological interactions in CML treatment ⋮ Bifurcation patterns in generalized models for the dynamics of normal and leukemic stem cells with signaling ⋮ Mathematics + Cancer: An Undergraduate "Bridge" Course in Applied Mathematics ⋮ STABILITY ANALYSIS OF A MATHEMATICAL MODEL FOR CHRONIC MYELOID LEUKEMIA ERADICATION ⋮ Mathematical models of leukaemia and its treatment: a review ⋮ Deterministic and Stochastic Dynamics of Chronic Myelogenous Leukaemia Stem Cells Subject to Hill-Function-Like Signaling ⋮ An analysis of strategic treatment interruptions during imatinib treatment of chronic myelogenous leukemia with imatinib-resistant mutations

Cites Work

• Predicting differential responses to structured treatment interruptions during HAART
• Dynamic multidrug therapies for HIV: Optimal and STI control approaches
• A Comparison of Three Methods for Selecting Values of Input Variables in the Analysis of Output from a Computer Code

This page was built for publication: Strategic treatment interruptions during imatinib treatment of chronic myelogenous leukemia